1. Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells
    Marina Pifano et al, 2017, Front. Oncol. CrossRef
  2. The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models
    JUAN GARONA et al, 2015 CrossRef
  3. Neurohormonal Regulation of Tumor Growth
    I. I. Khegai, 2018, Russ J Genet CrossRef
  4. Search of vasopressin analogs with antiproliferative activity on small-cell lung cancer: drug design based on two different approaches
    Marina Pifano et al, 2018, Future Medicinal Chemistry CrossRef
  5. Preclinical Efficacy of [V4Q5]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer
    Juan Garona et al, 2018, Cancer Res Treat CrossRef
  6. In vitro and in vivo evaluation of desmopressin-loaded poly(D,L-lactic-co-glycolic acid) nanoparticles for its potential use in cancer treatment
    Merari T Chevalier et al, 2018, Nanomedicine CrossRef
  7. Addition of vasopressin synthetic analogue [V4Q5]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models
    Juan Garona et al, 2016, Clin Exp Metastasis CrossRef
  8. Development and therapeutic potential of vasopressin synthetic analog [V4Q5]dDAVP as a novel anticancer agent
    Juan Garona et al, 2020 CrossRef
  9. Exploiting cancer’s phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy
    Mahjabin Khan et al, 2017, Oncotarget CrossRef
  10. Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides
    Mladena Glavaš et al, 2022, IJMS CrossRef
  11. Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic diabetes insipidus
    Beril Erdem Tuncdemir, 2022, Journal of Receptors and Signal Transduction CrossRef
  12. Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans
    Laine M. Heidman et al, 2022 CrossRef